Siren Biotechnology
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. No cookies to display. No cookies to display. No cookies to display. No cookies to display. At Siren, we are combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer. Brain Cancer: An Ideal Initial Setting Brain tumors are our first stop en route to re-inventing solid tumor cancer therapy overall. These are devastating diseases with limited treatment options. Our AAV immuno-gene therapy is designed to overcome key challenges that have caused past therapies to fail. We are completely reimagining how to treat these cancers. We have the scientific expertise, motivation, and passion to tackle key challenges, solve big problems, and deliver on the massive potential of AAV immuno-gene therapy for patien
Changing the game to help cancer patients win At Siren, we are combining the promise of two transformative therapeutic technologies, AAV gene therapy and cytokine immunotherapy, into a single, powerful new treatment modality to fight cancer. Our Vision For AAV immuno-gene therapy to be the cornerstone treatment for any solid tumor Brain Cancer: An Ideal Initial Setting Brain tumors are our first stop en route to re-inventing solid tumor cancer therapy overall. These are devastating diseases with limited treatment options. Our AAV immuno-gene therapy is designed to overcome key…
saved by
related reading
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- I’m going to cure my girlfriend’s brain tumor.andrewjrod.substack.com
- List of Biotechnology Companies to Watch – AI Expanded Versionsubstack.com
- Immunotherapy for Cancer - NCIcancer.gov
- Introduction to AAV as a Gene Therapy Vector, Part 2substack.com
- Medicine's Endgamenotboring.co
- Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov
- Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
- Introduction to AAV as a Gene Therapy Vector, Part 1substack.com
- Asimov — Intelligent Designasimov.com
- Delivering gene therapy’s promise - Dyno Therapeuticsdynotx.substack.com
- Understanding Cell + Gene Therapypatienteducation.asgct.org